Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02AYD
|
||||
| Former ID |
DIB019447
|
||||
| Drug Name |
compound 32
|
||||
| Drug Type |
Small molecular drug
|
||||
| Formula |
C20H29N5O2
|
||||
| InChI |
InChI=1S/C20H29N5O2/c1-2-4-6-16(5-3-1)24-20-17-13-19(21-14-18(17)22-15-23-20)27-12-9-25-7-10-26-11-8-25/h13-16H,1-12H2,(H,22,23,24)
|
||||
| InChIKey |
OGIVDFLCEHDQBN-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Metabotropicglutamate receptor 1 | Target Info | Modulator (allosteric modulator) | [530023] | |
| References | |||||
| Ref 530023 | Bioorg Med Chem Lett. 2009 Apr 15;19(8):2190-4. Epub 2009 Mar 3.In vitro and in vivo SAR of pyrido[3,4-d]pyramid-4-ylamine based mGluR1 antagonists. | ||||
| Ref 541495 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6351). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.